IDEXX Laboratories Director Files Form 144 for $1.17M Option Exercise & Sale
IDEXX LABORATORIES INC /DE
Subscribe to track IDXX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Analysis • Company: IDEXX LABORATORIES, INC. ($IDXX) • Insider: LAWRENCE D KINGSLEY (Director) • Proposed Sale: 2,203 shares of Common Stock • Total Market Value: $1,172,178.19 (~$532.08/share) • Acquisition Source: Stock Option Exercise on 09/04/2026 • Broker: Morgan Stanley Smith Barney LLC
Comprehensive Analysis
IDEXX Laboratories, Inc. (IDXX) – Form 144 Filing Analysis
Executive Summary
On September 4, 2026, Lawrence D. Kingsley, a Director of IDEXX Laboratories, Inc., filed a Form 144 notice of proposed sale covering 2,203 shares of common stock with an aggregate market value of approximately $1.17 million.
Transaction Details
- Filer: Lawrence D. Kingsley
- Relationship: Director
- Securities Class: Common Stock
- Units to Sell: 2,203 shares
- Aggregate Market Value: $1,172,178.19 (Implied price of ~$532.08 per share)
- Approximate Sale Date: September 4, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Origin of Securities: Acquired via cash exercise of stock options directly from the issuer on September 4, 2026.
Significance & Market Context
This Form 144 filing represents a standard exercise-and-sell transaction by a non-employee director. The transaction volume accounts for a minimal fraction of IDEXX Laboratories' 78.78 million outstanding shares and does not indicate an unexpected shift in insider sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.